Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GHNYSE:HIMSNASDAQ:LFSTNASDAQ:OPCH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGHGuardant Health$44.97-0.5%$43.55$15.81▼$50.89$5.55B1.452.14 million shs1.84 million shsHIMSHims & Hers Health$27.24+1.1%$37.26$11.20▼$72.98$6.05B1.6515.34 million shs18.47 million shsLFSTLifeStance Health Group$6.70-0.1%$7.15$4.64▼$8.61$2.58B1.31.61 million shs1.09 million shsOPCHOption Care Health$32.09-0.6%$33.33$21.39▼$35.53$5.27B1.071.80 million shs1.84 million shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGHGuardant Health-0.46%+9.31%+2.55%+22.67%+174.37%HIMSHims & Hers Health+1.19%+1.70%-13.40%-2.02%+120.04%LFSTLifeStance Health Group-0.15%-1.03%-0.59%-16.15%+17.75%OPCHOption Care Health-0.57%-4.76%-6.54%+10.03%+6.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGHGuardant Health3.8103 of 5 stars2.53.00.04.33.32.50.6HIMSHims & Hers Health3.5827 of 5 stars4.12.00.00.02.03.31.9LFSTLifeStance Health Group1.8169 of 5 stars3.41.00.00.01.42.50.6OPCHOption Care Health3.1545 of 5 stars1.43.00.04.23.62.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGHGuardant Health 3.05Buy$49.008.96% UpsideHIMSHims & Hers Health 2.21Hold$38.2540.41% UpsideLFSTLifeStance Health Group 2.71Moderate Buy$8.5828.11% UpsideOPCHOption Care Health 2.75Moderate Buy$33.002.85% UpsideCurrent Analyst Ratings BreakdownLatest LFST, HIMS, GH, and OPCH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/10/2025GHGuardant HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$60.00 ➝ $55.004/10/2025GHGuardant HealthMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$55.004/10/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$39.00 ➝ $33.004/9/2025GHGuardant HealthMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/8/2025LFSTLifeStance Health GroupKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$9.004/7/2025LFSTLifeStance Health GroupKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/3/2025LFSTLifeStance Health GroupCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$8.004/2/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell ➝ Sell3/26/2025GHGuardant HealthStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$55.00 ➝ $55.003/18/2025HIMSHims & Hers HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderperform ➝ Underperform$21.00 ➝ $22.003/6/2025GHGuardant HealthMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$42.00 ➝ $52.00(Data available from 4/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGHGuardant Health$739.02M7.51N/AN/A$1.34 per share33.56HIMSHims & Hers Health$1.48B4.10N/AN/A$1.61 per share16.92LFSTLifeStance Health Group$1.25B2.06N/AN/A$3.77 per share1.78OPCHOption Care Health$5.00B1.05$1.87 per share17.19$8.03 per share4.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGHGuardant Health-$479.45M-$3.56N/AN/AN/A-59.05%-19,157.20%-25.96%4/30/2025 (Estimated)HIMSHims & Hers Health-$23.55M$0.5461.9152.39N/A8.19%10.97%8.29%5/5/2025 (Estimated)LFSTLifeStance Health Group-$186.26M-$0.16N/AN/AN/A-7.90%-6.66%-4.51%5/8/2025 (Estimated)OPCHOption Care Health$267.09M$1.2226.9625.462.304.37%15.30%6.57%4/29/2025 (Estimated)Latest LFST, HIMS, GH, and OPCH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025LFSTLifeStance Health Group-$0.03N/AN/AN/A$332.71 millionN/A5/5/2025Q1 2025HIMSHims & Hers Health$0.11N/AN/AN/A$535.21 millionN/A4/30/2025Q1 2025GHGuardant Health-$0.57N/AN/AN/A$189.91 millionN/A4/29/2025Q1 2025OPCHOption Care Health$0.36N/AN/AN/A$1.26 billionN/A2/24/2025Q4 2024HIMSHims & Hers Health$0.09$0.11+$0.02$0.11$494.56 million$481.14 million2/20/2025Q4 2024GHGuardant Health-$0.75-$0.90-$0.15-$0.90$192.50 million$201.81 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGHGuardant HealthN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/ALFSTLifeStance Health GroupN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGHGuardant HealthN/A6.225.85HIMSHims & Hers HealthN/A2.141.82LFSTLifeStance Health Group0.191.321.32OPCHOption Care Health0.771.731.32Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGHGuardant Health92.60%HIMSHims & Hers Health63.52%LFSTLifeStance Health Group85.50%OPCHOption Care Health98.05%Insider OwnershipCompanyInsider OwnershipGHGuardant Health5.50%HIMSHims & Hers Health17.71%LFSTLifeStance Health Group6.60%OPCHOption Care Health0.64%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGHGuardant Health1,790123.42 million116.76 millionNot OptionableHIMSHims & Hers Health650222.17 million179.79 millionOptionableLFSTLifeStance Health Group6,640384.55 million357.39 millionOptionableOPCHOption Care Health5,600164.24 million169.09 millionOptionableLFST, HIMS, GH, and OPCH HeadlinesRecent News About These CompaniesBank of Nova Scotia Acquires Shares of 9,843 Option Care Health, Inc. (NASDAQ:OPCH)April 18 at 3:50 AM | marketbeat.comBest Growth Stocks to Buy for April 17thApril 17 at 6:20 AM | zacks.comOption Care Health, Inc. (NASDAQ:OPCH) Stock Position Decreased by Fmr LLCApril 16 at 3:55 AM | marketbeat.com303,956 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Acquired by Granite Investment Partners LLCApril 15 at 7:40 AM | marketbeat.comBest Growth Stocks to Buy for April 15thApril 15 at 5:00 AM | zacks.comOPCH or CHE: Which Is the Better Value Stock Right Now?April 14, 2025 | zacks.comWhetstone Capital Advisors LLC Makes New Investment in Option Care Health, Inc. (NASDAQ:OPCH)April 13, 2025 | marketbeat.comGeode Capital Management LLC Reduces Position in Option Care Health, Inc. (NASDAQ:OPCH)April 13, 2025 | marketbeat.comFranklin Resources Inc. Trims Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)April 13, 2025 | marketbeat.comExodusPoint Capital Management LP Increases Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)April 12, 2025 | marketbeat.comVyvgart for self-administration ‘immaterial’ to Option Care, says JPMorganApril 11, 2025 | markets.businessinsider.comAlliancebernstein L.P. Increases Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)April 11, 2025 | marketbeat.comCalifornia Public Employees Retirement System Lowers Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)April 11, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Raises Holdings in Option Care Health, Inc. (NASDAQ:OPCH)April 11, 2025 | marketbeat.com4 Stocks to Watch in a Dynamic Outpatient Home Health IndustryApril 10, 2025 | zacks.com4 Stocks to Watch in a Dynamic Outpatient Home Health IndustryApril 10, 2025 | zacks.comBest Growth Stocks to Buy for April 9thApril 9, 2025 | zacks.comBest Growth Stocks to Buy for April 9thApril 9, 2025 | zacks.comOption Care Health, Inc. (NASDAQ:OPCH) Shares Bought by JPMorgan Chase & Co.April 9, 2025 | marketbeat.com90,500 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Purchased by Prospector Partners LLCApril 8, 2025 | marketbeat.comOption Care Health, Inc. (NASDAQ:OPCH) Stake Raised by Landscape Capital Management L.L.C.April 8, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?By Jeffrey Neal Johnson | March 21, 2025View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?5 Highest-Rated Dividend Stocks According to MarketBeatBy Thomas Hughes | April 10, 2025View 5 Highest-Rated Dividend Stocks According to MarketBeat5 Hot Stock Buys for Investors in AprilBy Thomas Hughes | April 1, 2025View 5 Hot Stock Buys for Investors in AprilAre Short Sellers Wrong About These 3 Semiconductor Stocks?By Leo Miller | April 4, 2025View Are Short Sellers Wrong About These 3 Semiconductor Stocks?Word-of-Mouth Winners: 2 Stocks Growing Without Big Ad BudgetsBy Leo Miller | March 21, 2025View Word-of-Mouth Winners: 2 Stocks Growing Without Big Ad BudgetsLFST, HIMS, GH, and OPCH Company DescriptionsGuardant Health NASDAQ:GH$44.97 -0.21 (-0.46%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$45.01 +0.04 (+0.09%) As of 04/17/2025 05:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Hims & Hers Health NYSE:HIMS$27.24 +0.29 (+1.08%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$27.34 +0.09 (+0.35%) As of 04/17/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.LifeStance Health Group NASDAQ:LFST$6.70 -0.01 (-0.15%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$6.70 +0.00 (+0.07%) As of 04/17/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.Option Care Health NASDAQ:OPCH$32.08 -0.19 (-0.57%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$32.02 -0.06 (-0.20%) As of 04/17/2025 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Archer Aviation Unveils NYC Network Ahead of Key Earnings Report Joby Aviation Stock Presents an Opportunity in the Turbulence Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally Tariff-Resistant Kinder Morgan Is a Good Buy in 2025 Rocket Lab's Growth Potential Gains Altitude on Defense News Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks Tariff-Resistant Abbott Laboratories on Track for New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
